Location: Rio De Janeiro, Brazil
CIK: 0001536562 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Jan 23, 2019
Total Value: $82.34M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| KHC | KRAFT HEINZ CO/THE | 550,000 | $23.67M | 28.7% | $43.04 | — | — | Put | 500754106 |
| EWZ | ISHARES MSCI BRAZIL ETF | 500,000 | $19.1M | 23.2% | $38.20 | $38.72 | -1.3% | ETP | 464286400 |
| — | GENERAL ELECTRIC CO | 1,600,000 | $12.11M | 14.7% | $7.57 | $7.57 | — | Common Stock | 369604103 |
| — | OI SA-ADR | 2,827,201 | $4.524M | 5.5% | $1.60 | $2.42 | — | ADR | 670851500 |
| EEM | ISHARES MSCI EMERGING MARKET | 50,000 | $1.953M | 2.4% | $39.06 | $46.29 | -15.6% | Call | 464287234 |
| UNH | UNITEDHEALTH GROUP INC | 5,893 | $1.468M | 1.8% | $249.11 * | $235.05 | -5.5% | Common Stock | 91324P102 |
| — | SPDR S&P OIL & GAS EXP & PR | 50,000 | $1.327M | 1.6% | $26.54 | — | — | Call | 78464A730 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 12,292 | $1.047M | 1.3% | $85.18 | $99.82 | -14.7% | Common Stock | 09061G101 |
| INCY | INCYTE CORP | 14,916 | $949K | 1.2% | $63.62 | $89.73 | -29.1% | Common Stock | 45337C102 |
| — | SEATTLE GENETICS INC | 16,524 | $936K | 1.1% | $56.64 | $59.29 | — | Common Stock | 812578102 |
| ILMN | ILLUMINA INC | 2,917 | $875K | 1.1% | $299.97 * | $309.79 | -5.8% | Common Stock | 452327109 |
| PAGS | PAGSEGURO DIGITAL LTD-CL A | 43,000 | $805K | 1.0% | $18.72 | $24.54 | -23.7% | Common Stock | G68707101 |
| SRPT | SAREPTA THERAPEUTICS INC | 7,166 | $782K | 0.9% | $109.13 | $125.06 | -12.7% | Common Stock | 803607100 |
| — | ALEXION PHARMACEUTICALS INC | 6,449 | $628K | 0.8% | $97.38 | $97.38 | — | Common Stock | 015351109 |
| HUM | HUMANA INC | 2,044 | $586K | 0.7% | $286.69 * | $297.93 | -9.5% | Common Stock | 444859102 |
| BMY | BRISTOL-MYERS SQUIBB CO | 10,496 | $546K | 0.7% | $52.02 * | $44.98 | -11.8% | Common Stock | 110122108 |
| CI | CIGNA CORP | 2,850 | $541K | 0.7% | $189.82 * | $190.77 | -9.0% | Common Stock | 125523100 |
| ONC | BEIGENE LTD-ADR | 3,757 | $527K | 0.6% | $140.27 | $132.61 | +5.8% | ADR | 07725L102 |
| CNC | CENTENE CORP | 4,160 | $480K | 0.6% | $115.38 * | $66.95 | -13.9% | Common Stock | 15135B101 |
| — | SAGE THERAPEUTICS INC | 4,983 | $477K | 0.6% | $95.73 | $95.73 | — | Common Stock | 78667J108 |
| BSX | BOSTON SCIENTIFIC CORP | 12,271 | $434K | 0.5% | $35.37 | $34.93 | +1.2% | Common Stock | 101137107 |
| ABT | ABBOTT LABORATORIES | 5,781 | $418K | 0.5% | $72.31 * | $62.14 | +3.0% | Common Stock | 002824100 |
| DXCM | DEXCOM INC | 3,433 | $411K | 0.5% | $119.72 * | $31.72 | -5.6% | Common Stock | 252131107 |
| EWZ | ISHARES MSCI BRAZIL ETF | 10,000 | $382K | 0.5% | $38.20 | $38.72 | -1.3% | Put | 464286400 |
| VRTX | VERTEX PHARMACEUTICALS INC | 2,245 | $372K | 0.5% | $165.70 | $173.27 | -4.4% | Common Stock | 92532F100 |
| EXAS | EXACT SCIENCES CORP | 5,863 | $370K | 0.4% | $63.11 | $68.63 | -8.1% | Common Stock | 30063P105 |
| MRK | MERCK & CO. INC. | 4,716 | $360K | 0.4% | $76.34 * | $56.50 | +3.9% | Common Stock | 58933Y105 |
| EXEL | EXELIXIS INC | 17,215 | $339K | 0.4% | $19.69 | $23.58 | -16.6% | Common Stock | 30161Q104 |
| EW | EDWARDS LIFESCIENCES CORP | 2,208 | $338K | 0.4% | $153.08 * | $50.60 | +0.9% | Common Stock | 28176E108 |
| — | ALLERGAN PLC | 2,466 | $330K | 0.4% | $133.82 | $133.82 | — | Common Stock | G0177J108 |
| — | BLUEBIRD BIO INC | 3,281 | $325K | 0.4% | $99.06 | $99.06 | — | Common Stock | 09609G100 |
| ABBV | ABBVIE INC | 3,454 | $318K | 0.4% | $92.07 * | $64.80 | +5.0% | Common Stock | 00287Y109 |
| — | ASSEMBLY BIOSCIENCES INC | 13,897 | $314K | 0.4% | $22.59 | $37.11 | — | Common Stock | 045396108 |
| ELV | ANTHEM INC | 1,177 | $309K | 0.4% | $262.53 * | $250.16 | -4.3% | Common Stock | 036752103 |
| LLY | ELI LILLY & CO | 2,631 | $304K | 0.4% | $115.55 * | $101.37 | +3.9% | Common Stock | 532457108 |
| — | CELGENE CORP | 4,551 | $292K | 0.4% | $64.16 | $64.16 | — | Common Stock | 151020104 |
| FOLD | AMICUS THERAPEUTICS INC | 30,287 | $290K | 0.4% | $9.58 | $13.65 | -29.8% | Common Stock | 03152W109 |
| — | GENOMIC HEALTH INC | 4,438 | $286K | 0.3% | $64.44 | $64.44 | — | Common Stock | 37244C101 |
| — | AERIE PHARMACEUTICALS INC | 7,723 | $279K | 0.3% | $36.13 | $36.13 | — | Common Stock | 00771V108 |
| BIIB | BIOGEN INC | 855 | $257K | 0.3% | $300.58 | $319.14 | -5.7% | Common Stock | 09062X103 |
| — | GW PHARMACEUTICALS -ADR | 2,480 | $242K | 0.3% | $97.58 | $97.58 | — | ADR | 36197T103 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 5,764 | $237K | 0.3% | $41.12 | $41.12 | — | Common Stock | 37890U108 |
| PRQR | PROQR THERAPEUTICS NV | 14,870 | $235K | 0.3% | $15.80 | $10.63 | +48.5% | Common Stock | N71542109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2,997 | $214K | 0.3% | $71.40 | $95.81 | -25.5% | Common Stock | 64125C109 |
| REGN | REGENERON PHARMACEUTICALS | 548 | $205K | 0.2% | $374.09 | $364.00 | +2.0% | Common Stock | 75886F107 |
| ARGX | ARGENX SE - ADR | 2,100 | $202K | 0.2% | $96.19 | $88.85 | +8.1% | ADR | 04016X101 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 23,724 | $191K | 0.2% | $8.05 | $6.72 | +20.2% | Common Stock | 09058V103 |
| NTRA | NATERA INC | 12,238 | $171K | 0.2% | $13.97 | $24.17 | -42.2% | Common Stock | 632307104 |
| — | IMMUNOMEDICS INC | 11,855 | $169K | 0.2% | $14.26 | $20.87 | — | Common Stock | 452907108 |
| — | AMARIN CORP PLC -ADR | 11,024 | $150K | 0.2% | $13.61 | $13.61 | — | ADR | 023111206 |
| — | EPIZYME INC | 12,398 | $76,000 | 0.1% | $6.13 | $6.13 | — | Common Stock | 29428V104 |
| — | DBV TECHNOLOGIES SA-SPON ADR | 10,213 | $66,000 | 0.1% | $6.46 | $22.48 | — | ADR | 23306J101 |
| — | PROTEOSTASIS THERAPEUTICS IN | 19,790 | $64,000 | 0.1% | $3.23 | $3.23 | — | Common Stock | 74373B109 |
| OCUL | OCULAR THERAPEUTIX INC | 12,568 | $50,000 | 0.1% | $3.98 | $5.51 | -27.8% | Common Stock | 67576A100 |
| — | OI SA-ADR | 28,567 | $7,000 | 0.0% | $0.25 | $0.25 | — | ADR | 670851401 |